Improving the Specificity of Screening for Lethal Prostate Cancer Using Prostate-specific Antigen and a Panel of Kallikrein Markers: A Nested Case-Control Study.

Summary, in English

A disadvantage of prostate-specific antigen (PSA) for the early detection of prostate cancer (PCa) is that many men must be screened, biopsied, and diagnosed to prevent one death.

• Författare: Pär Stattin; Andrew J Vickers; Daniel D Sjoberg; Robert Johansson; Torvald Granfors; Mattias Johansson; Kim Pettersson; Peter T Scardino; Göran Hallmans; Hans Lilja
• Avdelning/ar: Klinisk kemi, Malmö; EpiHealth: Epidemiology for Health
• Publiceringsår: 2015
• Språk: Engelska
• Sidor: 207-213
• Publikation/Tidskrift/Serie: European Urology
• Volym: 68
• Issue: 2
• Fulltext: - 2 MB; Download statistics
• Länkar: http://www.ncbi.nlm.nih.gov/pubmed/25682340?dopt=Abstract; http://dx.doi.org/10.1016/j.eururo.2015.01.009
• Dokumenttyp: Artikel i tidskrift
• Förlag: Elsevier
• Ämne: Urology and Nephrology
• Status: Published
• Forskningsgrupp: Clinical Chemistry, Malmö
• ISBN/ISSN/Övrigt: ISSN: 1873-7560